Doxorubicin/Pemetrexed Followed by Docetaxel Versus Doxorubicin/Cyclophosphamide Followed by Docetaxel as Neoadjuvant Treatment for Early-Stage Breast Cancer: A Randomized Phase II Trial-Reference-Cited by-同舟云学术

Doxorubicin/Pemetrexed Followed by Docetaxel Versus Doxorubicin/Cyclophosphamide Followed by Docetaxel as Neoadjuvant Treatment for Early-Stage Breast Cancer: A Randomized Phase II Trial

Published:2007-04 Issue:7 Volume:7 Page:555-558
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Schneeweiss Andreas,Lauschner Ilka,Ruiz Amparo,Guerrero Angel,Sánchez-Rovira Pedro,Seguí Miguel Angel,Goerke Kay,Wolf Michael,Manikhas Alexey G.,Wacker Juergen,Marmé Frederik,Lichter Peter,Sinn Hans-Peter,Sohn Christof,Mansouri Kambiz,Bauknecht Thomas,Hahn Meinhard

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference18 articles.

1. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations;Kaufmann;J Clin Oncol,2003

2. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27;Bear;J Clin Oncol,2003

3. Dose-dense sequential epirubicin-paclitaxel as preoperative treatment of breast cancer: results of a randomised AGO study;Untch;Proc Am Soc Clin Oncol,2002

4. Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group;von Minckwitz;J Clin Oncol,2005

5. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18;Wolmark;J Natl Cancer Inst Monogr,2001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia-Inducible Factor-1 Alpha Expression Is Predictive of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy;Cancers;2022-11-02

2. On the identification of predictive biomarkers: Detecting treatment-by-gene interaction in high-dimensional data;Computational Statistics & Data Analysis;2012-05

3. A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer;Annals of Oncology;2011-03

4. Genetic Determinants of Pemetrexed Responsiveness and Nonresponsiveness in Non-small Cell Lung Cancer Cells;Journal of Thoracic Oncology;2010-08

5. Trayectoria clínica para mujer con cáncer de mama localmente avanzado en tratamiento con quimioterapia neoadyuvante;Enfermería Clínica;2010-01